Sign In
Buy SMMT
$15.07
+0.210 (+1.41%)
At Close: Jun 03, 2026
Summit Therapeutics to Host Third Quarter 2024 Financial Results & Operational Progress Call on October 30, 2024
04:15pm, Wednesday, 23'rd Oct 2024
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) will host an earnings call to announce its third quarter 2024 financial results
Summit Stock Skyrockets Nearly 700% YTD: Time to Sell or Hold?
10:46am, Wednesday, 23'rd Oct 2024
The rally in SMMT stock is driven by encouraging updates on its oncology candidate, which has the potential to become the next standard of care in the NSCLC space.
Billionaire Israel Englander Just Quietly Took a Stake in This Potentially Lucrative Pharmaceutical Stock. Should You?
07:00am, Tuesday, 22'nd Oct 2024
Millennium Management just initiated a position in a small biotech company developing a new cancer drug.
Up 700% This Year, Is It Too Late to Invest in This Stock?
06:30am, Tuesday, 15'th Oct 2024
The shares have experienced a pullback in the past couple of weeks.
Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics
12:11pm, Sunday, 13'th Oct 2024
It's hard to go wrong with either company, but one is more appealing.
3 Things You Need to Know If You Buy Summit Therapeutics Stock Today
09:15am, Saturday, 12'th Oct 2024
It's easier to invest confidently when you know both the pros and the cons in full.
2 Soaring Stocks That Could Climb Another 112% and 120%, According to Wall Street Analysts
05:29am, Monday, 07'th Oct 2024
The investment bank analysts who follow these stocks think they can soar even further, with some caveats.
Is Summit Therapeutics a Millionaire Maker?
11:12am, Saturday, 05'th Oct 2024
This company's promising cancer drug could challenge Merck's $25 billion crown jewel.
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Friday, 04'th Oct 2024
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of
Summit Therapeutics Stock Jumps as Lung Cancer Drug Placed on FDA Fast Track
10:35am, Friday, 04'th Oct 2024
Summit Therapeutics (SMMT) shares surged Friday morning, a day after after the biopharmaceutical company said its developmental lung cancer drug was granted Fast Track designation by the Food and Drug
Could Summit Therapeutics Become the Next Merck?
07:45am, Friday, 04'th Oct 2024
Recent developments are forcing comparisons between these two drugmakers.
Summit Therapeutics Announces Completion of Enrollment in Its Phase III HARMONi Trial in 2L+ EGFRm NSCLC
04:15pm, Thursday, 03'rd Oct 2024
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that we have completed enrollment in our HARMONi clinical trial
Where Will Summit Therapeutics Be in 3 Years?
09:00am, Thursday, 03'rd Oct 2024
There's a lot riding on how its collaborator's studies end up performing.
Has Summit Therapeutics Stock Already Peaked?
08:15am, Wednesday, 02'nd Oct 2024
Summit Therapeutics stock is up a remarkable 700% this year.
Is Summit Therapeutics Stock a Buy?
06:28am, Monday, 30'th Sep 2024
Summit Therapeutics is having a great year, and it could realize revenue soon. Its partner Akeso could keep its pipeline packed with late-stage programs.
